Avanos MedicalAVNS +0.08%62 OCF Margin % is -6.75% as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.43 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Avanos Medical ranks worse than 52.02% on this metric.
The historical rank and industry rank for Avanos Medical's OCF Margin % or its related term are showing as below:
AVNS'
s OCF Margin % Range Over the Past 10 Years
Min: -22.32 Med: 11.97 Max: 33.35
Current: 5.13
During the past 13 years, the highest OCF Margin % of Avanos Medical was 33.35%. The lowest was -22.32%. And the median was 11.97%.
AVNS's OCF Margin % is ranked worse than 52.02% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs AVNS: 5.13
Avanos Medical OCF Margin % Related Terms
Avanos Medical OCF Margin % Historical Data
* Premium members only.
The historical data trend for Avanos Medical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Avanos Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Avanos Medical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (AVNS) has a OCF Margin % of -6.75% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avanos Medical and its competitors. According to the industry distribution chart, Avanos Medical ranks #424 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 52%.
Is Avanos Medical's OCF Margin % too high?
Avanos Medical's current OCF Margin % is -6.75%. Based on the distribution chart, Avanos Medical ranks #424 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's OCF Margin % compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #424 out of 815 companies for OCF Margin %. This places Avanos Medical in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current OCF Margin % is -6.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.43, compared to a current price of $24.95 — trading 28.4% above its estimated fair value. The current OCF Margin % is -6.75%. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Avanos Medical (AVNS), the current OCF Margin % is -6.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.4% above its estimated GF Value™ of $19.43.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
OCF Margin %: -6.75%
GF Value™: $19.43 vs. price of $24.95 (28.4% above fair value)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
